Proteome Sciences and Icon Collaborate on Mass Spec Assays for Pharma Biomarker Development

Proteome Sciences will provide Icon's clients with its expertise in single-reaction monitoring mass spectrometry, said a company official. The partners' first joint project is the development of an SRM assay measuring a biomarker for an unnamed drugmaker.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.